Timothy Keutzer, Chief Operating Officer at Spero Therapeutics, Inc. (SPRO), sold 30,971 shares at $1.36 ($42K) on 2024-02-02, disclosed to the SEC on 2024-02-05.
Open-market sale of $42k SPRO by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SPRO | SELL | 2025-09-03 | $3K | — | Filing → |
| SPRO | SELL | 2025-02-05 | $44K | — | Filing → |
| SPRO | SELL | 2024-08-29 | $3K | — | Filing → |